Heart Health Archive

For people who have both heart disease and arthritis, two of the main treatments—exercise and medications—require careful planning and attention. Joint pain makes certain types of exercise difficult, and commonly used drugs for both conditions can have potentially serious interactions.

Most people don't need to fast before a lipid test because the difference between LDL cholesterol values when fasting or not fasting is very small. But people who have had high triglyceride levels should fast prior to the test.

Varicose veins are not just unsightly and uncomfortable; they can also be harbingers of more serious conditions, including deep-vein blood clots and venous ulcers. Ablation therapies to eradicate varicose veins can lower these risks. People can also try simple strategies to prevent and improve varicose veins, including doing exercises that work their calf muscles, elevating their legs, and wearing compression stockings.

People who follow a healthy lifestyle can still have the early stages of coronary artery disease (CAD), the most common type of heart disease. There are many ways people can find out if they have CAD. This includes paying attention to whether exercise causes discomfort, doing a 10-year heart risk assessment, and seeing their doctor for diagnostic testing, such as a coronary artery calcium scan, a resting electrocardiogram, a walking stress test, or an echocardiogram. A doctor uses this information to determine the best treatment path.

Briefly running or climbing stairs are examples of vigorous intermittent lifestyle physical activity (VILPA). Just a few minutes of VILPA per day was linked to a lower risk of heart-related problems among women who don't exercise, a 2024 study found.

In a 2024 study, people with a habit of eating dark chocolate—about an ounce a day—were less likely to develop diabetes compared to those who didn't consume it.

A condition caused by spontaneous genetic mutations in bone marrow cells, known as clonal hematopoiesis of indeterminate significance (CHIP), is linked to an increased risk of cardiovascular disease. Some of these mutations are clearly related to inflammation, a well-known contributor to the buildup of fatty plaque inside arteries. Experts hope that future research on CHIP will eventually lead to genetically directed therapies to address the condition.